258 related articles for article (PubMed ID: 12800575)
1. How Genentech got it.
Stipp D
Fortune; 2003 Jun; 147(11):81-2, 84, 86 passim. PubMed ID: 12800575
[No Abstract] [Full Text] [Related]
2. Investing in oncology biotech stocks.
Feuerstein A
Clin Adv Hematol Oncol; 2007 Nov; 5(11):879-80. PubMed ID: 18185485
[No Abstract] [Full Text] [Related]
3. Biotech bonanza.
Stipp D
Fortune; 1999 Nov; 140(9):333-4. PubMed ID: 10623111
[No Abstract] [Full Text] [Related]
4. Nasdaq restructures biotech index.
Morrison C
Nat Biotechnol; 2001 Mar; 19(3):187. PubMed ID: 11231518
[No Abstract] [Full Text] [Related]
5. Rising costs hold up drug discovery.
Miller HI
Nature; 1998 Oct; 395(6705):835. PubMed ID: 9804407
[No Abstract] [Full Text] [Related]
6. Spinning the wheel on ImClone.
Varchaver N
Fortune; 2003 Apr; 147(8):123-5. PubMed ID: 12728651
[No Abstract] [Full Text] [Related]
7. How the street sees biotech.
Lashinsky A
Fortune; 2003 Jun; 147(11):86. PubMed ID: 12800576
[No Abstract] [Full Text] [Related]
8. Can personalized drugs pay off?
Stipp D
Fortune; 2002 May; 145(10):168. PubMed ID: 12025349
[No Abstract] [Full Text] [Related]
9. Public biotech 98: the numbers.
Lähteenmäki R; Michael A; Marshall A
Nat Biotechnol; 1999 May; 17(5):429-32. PubMed ID: 10331795
[No Abstract] [Full Text] [Related]
10. When a long shot is worth a shot.
Jacobs T; Fischer J
Nat Biotechnol; 2005 Jul; 23(7):805. PubMed ID: 16003361
[No Abstract] [Full Text] [Related]
11. Roche vows to keep Genentech culture.
Hayden EC
Nature; 2009 Mar; 458(7236):270. PubMed ID: 19295574
[No Abstract] [Full Text] [Related]
12. A special biotech speculation.
Jacobs T
Nat Biotechnol; 2006 Jun; 24(6):622. PubMed ID: 16763586
[No Abstract] [Full Text] [Related]
13. Hidden in plain view.
Jacobs T
Nat Biotechnol; 2003 Jun; 21(6):603. PubMed ID: 12776141
[No Abstract] [Full Text] [Related]
14. Eli Lilly enters venture capital arena.
Fletcher L
Nat Biotechnol; 2001 Nov; 19(11):997-8. PubMed ID: 11689830
[No Abstract] [Full Text] [Related]
15. No pain, no gain?
Jacobs T
Nat Biotechnol; 2005 Aug; 23(8):934. PubMed ID: 16082357
[No Abstract] [Full Text] [Related]
16. Great company, bad stock.
Jacobs T
Nat Biotechnol; 2005 Feb; 23(2):173. PubMed ID: 15696142
[No Abstract] [Full Text] [Related]
17. Finding new life in health stocks.
Armour LA
Fortune; 1997 Sep; 136(6):289-90, 292, 294. PubMed ID: 10173398
[No Abstract] [Full Text] [Related]
18. Any diamonds in the diagnostic coal?
Jacobs T
Nat Biotechnol; 2006 Aug; 24(8):930. PubMed ID: 16900133
[No Abstract] [Full Text] [Related]
19. IPO floodgates unlikely to open after Ark floatation.
Louët S
Nat Biotechnol; 2004 Apr; 22(4):367-8. PubMed ID: 15060538
[No Abstract] [Full Text] [Related]
20. Bugs or drugs, tortoises or hares?
Jacobs T
Nat Biotechnol; 2005 Mar; 23(3):293. PubMed ID: 15765079
[No Abstract] [Full Text] [Related]
[Next] [New Search]